BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26597365)

  • 1. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
    Sadot E; Reidy-Lagunes DL; Tang LH; Do RK; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Groot Koerkamp B; Untch BR; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg Oncol; 2016 Apr; 23(4):1361-70. PubMed ID: 26597365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.
    Gaujoux S; Partelli S; Maire F; D'Onofrio M; Larroque B; Tamburrino D; Sauvanet A; Falconi M; Ruszniewski P
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4784-9. PubMed ID: 24057286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
    Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors.
    de Mestier L; Védie AL; Faron M; Cros J; Rebours V; Hentic O; Do Cao C; Bardet P; Lévy P; Sauvanet A; Ruszniewski P; Hammel P
    Neuroendocrinology; 2020; 110(11-12):967-976. PubMed ID: 31791037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
    Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
    Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
    Masui T; Nagai K; Anazawa T; Kasai Y; Sato A; Nakano K; Uchida Y; Yogo A; Kawaguchi Y; Takaori K; Uemoto S
    Scand J Gastroenterol; 2020 Apr; 55(4):479-484. PubMed ID: 32223573
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
    Haynes AB; Deshpande V; Ingkakul T; Vagefi PA; Szymonifka J; Thayer SP; Ferrone CR; Wargo JA; Warshaw AL; Fernández-del Castillo C
    Arch Surg; 2011 May; 146(5):534-8. PubMed ID: 21576607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes.
    Cheema A; Weber J; Strosberg JR
    Ann Surg Oncol; 2012 Sep; 19(9):2932-6. PubMed ID: 22350605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.
    Lee LC; Grant CS; Salomao DR; Fletcher JG; Takahashi N; Fidler JL; Levy MJ; Huebner M
    Surgery; 2012 Dec; 152(6):965-74. PubMed ID: 23102679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor.
    Gao H; Liu L; Wang W; Xu H; Jin K; Wu C; Qi Z; Zhang S; Liu C; Xu J; Ni Q; Yu X
    Cancer Lett; 2018 Jan; 412():188-193. PubMed ID: 29107104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size.
    Kishi Y; Shimada K; Nara S; Esaki M; Hiraoka N; Kosuge T
    Ann Surg Oncol; 2014 Sep; 21(9):2882-8. PubMed ID: 24740828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
    Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
    JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
    Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.